Shareholders' Equity (Details) - Schedule of RSU activity - shares	12 Months Ended
	Dec. 31, 2021		Dec. 31, 2020
Schedule of RSU activity [Abstract]
RSU's outstanding at the beginning of the period	49,025		13,025
RSU's outstanding at the end of the period	196,000		49,025
RSU’s Granted	227,500	[1],[2],[3]	103,500	[4],[5]
RSU’s Exercised	(80,525)		(67,500)
RSU’s Forfeited

[1] On December 14, 2021, the Company granted five directors 144,000 RSU’s. The fair value of the shares at the date of the grant was $111. The RSU’s vest quarterly in advance over one year.

[2] On October 27, 2020, the Company, through Saffron, signed a contract with a consultant pursuant to which they were granted 40,000 options to purchase 40,000 shares. All options are exercisable at $0.001 per Share. The options vest immediately. The fair value of the stock options issued is $23 and was determined using the Black-Scholes option pricing model and the following assumptions: share price - $0.50; exercise price - $0.001; expected life – 1 year; annualized volatility – 237%; dividend yield – 0%; risk free rate – 0.12%. During the years ended December 31, 2021 and 2020, the Company recorded share-based expenses related to the options in the amount of $23 and $nil, respectively.

[3] On October 5, 2021, the Company granted a director 7,500 RSU’s. The fair value of the shares at the date of the grant was $18.

[4] On November 24, 2020, The Company granted two directors 30,000 RSU’s each, and one director 7,500 RSU’s. All these RSU’s vest immediately and have an exercise price of nil. The fair value of the RSU’s at the date of the grant was $128.

[5] On September 1, 2020, the Company, the Company granted the CFO 36,000 RSU’s with an exercise price of nil. The RSU’s vest quarterly over three years. The fair value of the RSU’s at the date of the grant was $30. During the years ended December 31, 2021 and 2020, the Company recorded share-based expenses related to the RSU’s in the amount of $10 and $3, respectively